1. Home
  2. SPCB vs CUE Comparison

SPCB vs CUE Comparison

Compare SPCB & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.48

Market Cap

45.3M

Sector

Technology

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.39

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
CUE
Founded
1988
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.3M
49.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SPCB
CUE
Price
$8.48
$0.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$3.00
AVG Volume (30 Days)
50.7K
1.7M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$7,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
$25.00
P/E Ratio
$10.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.06
$0.23
52 Week High
$18.95
$1.75

Technical Indicators

Market Signals
Indicator
SPCB
CUE
Relative Strength Index (RSI) 39.26 46.43
Support Level $8.98 $0.23
Resistance Level $9.47 $0.44
Average True Range (ATR) 0.49 0.05
MACD -0.08 0.02
Stochastic Oscillator 11.11 74.50

Price Performance

Historical Comparison
SPCB
CUE

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: